Barringer Technologies Inc. Forms Alliance to Market Its IONSCAN Technology to the Pharmaceutical and Specialty Chemical Marketplace
August 23, 2000 10:31 AM Eastern Time
WARREN, N.J.--(BUSINESS WIRE)--Aug. 23, 2000--Barringer Technologies Inc. BARR ; the world's leading developer and manufacturer of trace drug and explosive detection equipment, today announced that it has entered into a sales and marketing agreement with Cadrai, LLC to spearhead sales of its IONSCAN(R) product line into the pharmaceutical and specialty chemicals marketplace.
Kenneth Wood, President of Barringer Technologies commented, "Barringer believes that there are numerous applications for our IONSCAN(R) technology in the fast-growing pharmaceutical and specialty chemical industries. We believe that Cadrai's combination of industry know-how and relationships will accelerate Barringer's entrance into these markets."
John Carroll, President of Cadrai, LLC commented, "We are very enthusiastic about the potential of Barringer's IONSCAN(R) technology in the pharmaceutical and chemical marketplace. The benefits of fast analysis, low cost per sample, and easy-to-use instrumentation are extremely advantageous to the industry. We are excited about introducing Barringer's technology to the marketplace, as we believe there are many opportunities to augment operations, ranging from manufacturing to pharmaceutical R&D. We are confident that our seasoned sales force can assist Barringer in penetrating these promising new markets."
Cadrai is an instrument-industry management and marketing firm. The company includes analytical instrument sales and marketing professionals with in excess of 100 years of experience in these marketplaces. All are Certified Pharmaceutical Advisors (CPhA). Cadrai provides both a nationwide and international presence.
Headquartered in Warren, New Jersey, Barringer Technologies Inc. is principally engaged in developing, manufacturing, and marketing of high technology products for drug and explosive detection and other security and industrial applications. The Sabre 2000(R) and the IONSCAN(R) are the Company's proprietary trace particle drug and explosive detection units. |
